NCT01195571View on ClinicalTrials.gov

Safety Study of Four Chimera Cytomegalovirus (CMV) Vaccines in Healthy Adult Males 30-50 Years of Age

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Cytomegalovirus
Interventions
BIOLOGICAL

cmv vaccine

dose escalation study of 4 towne-toledo chimera vaccines

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

Sponsors
All Listed Sponsors
collaborator

International AIDS Vaccine Initiative

NETWORK

lead

CMV Research Foundation

OTHER